Helgebostad, R.; Revheim, M.-E.; Johnsrud, K.; Amlie, K.; Alavi, A.; Connelly, J.P.
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors. Diagnostics 2022, 12, 528.
https://doi.org/10.3390/diagnostics12020528
AMA Style
Helgebostad R, Revheim M-E, Johnsrud K, Amlie K, Alavi A, Connelly JP.
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors. Diagnostics. 2022; 12(2):528.
https://doi.org/10.3390/diagnostics12020528
Chicago/Turabian Style
Helgebostad, Rasmus, Mona-Elisabeth Revheim, Kjersti Johnsrud, Kristine Amlie, Abass Alavi, and James Patrick Connelly.
2022. "Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors" Diagnostics 12, no. 2: 528.
https://doi.org/10.3390/diagnostics12020528
APA Style
Helgebostad, R., Revheim, M.-E., Johnsrud, K., Amlie, K., Alavi, A., & Connelly, J. P.
(2022). Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors. Diagnostics, 12(2), 528.
https://doi.org/10.3390/diagnostics12020528